Market News & Trends
Haselmeier Announces the Launch of INSUPen EZ by Biocon
Haselmeier recently announced that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen EZ in India. The INSUPen EZ is a second- generation…
Metrics Scientist Awarded Patent for Zero-Order Release Technology
An expert scientist in pharmaceutical formulation development at Metrics Contract Services has been awarded a patent for intellectual property about controlled-release technology. The US Patent…
DPT Enhances Capabilities With New High-Speed Center
DPT Laboratories recently announced the implementation of a high-speed bottle filling center at its San Antonio location. One of three DPT Centers of Excellence, the…
SGS Life Science Services Completes Expanded Facility
SGS Life Science Services recently announced the completion of its expanded facility in Glasgow, UK, for the testing of cell banks for vaccines, gene and…
CSL Behring Signs Strategic Agreement With Enable Injections
CSL Behring LLC recently announced its affiliate company, CSL Behring AG, of Bern, Switzerland, and Enable Injections, LLC, of Franklin, OH, have signed a long-term…
MPI Research Acquires Research & Development Company
MPI Research recently announced it has acquired the assets of Kalamazoo, MI-based Jasper Clinical Research & Development, Inc. Jasper is a respected clinical research organization…
New Drugs Could Drive Celiac Disease Treatment Market Value Beyond $550 Million
The launches of Alba/Teva’s larazotide acetate and Alvine/AbbVie’s latiglutenase for treating celiac disease could drive sales in the US and five major European markets (5EU:…
Global Market for MicroRNA Research Tools to Reach $1 Billion by 2019
The last decade witnessed significant advancement in microRNA (miRNA) research leading to identification of novel miRNA genes, validation of miRNA targets and delineation of the…
Peter Bigelow Elected as PBOA's First-Ever Chairman
The Pharma & Biopharma Outsourcing Association (PBOA), a new non-profit trade association devoted to advancing the interests of CMOs, CDMOs and other service providers, has…
Mystic Pharmaceuticals Introduces ArrowFish Nasal Vaccine and Drug Delivery System
Mystic Pharmaceuticals, Inc. today announced the availability of its Arrowfish™ nasal drug and biologic delivery system. This new generation delivery system utilizes Mystic’s patented VersiDoser®…
Global Non-Hodgkin Lymphoma Therapeutics Market Value to Hit $9.2 Billion
The global Non-Hodgkin Lymphoma (NHL) treatment market will increase in value from $5.6 billion in 2013 to $9.2 billion by 2020, representing a Compound Annual…
Morrison & Foerster's BioMeter Index Shows Reemergence of Late-Stage Deals
Morrison & Foerster returns with its Q3 edition of BioMeter, which reveals a big jump in the number of deals and average payments for Phase…
TesoRx & Aspen Group Conclude Investment & Licensing Agreement
TesoRx Pharma, LLC (http://www.tesorx.com), a specialty pharmaceutical company, recently announced it has licensed select international rights to TSX-002, the first unmodified oral-Testosterone replacement therapy, to…
EMD Millipore Introduces Single-Use Process Container Film for High-Volume Biopharmaceutical Applications
EMD Millipore, the life science division of Merck KGaA of Darmstadt, Germany, has expanded its single-use film offerings with the introduction of PureFlex Plus film,…
West's Vial2Bag DC Device Receives US FDA 510(k) Clearance & CE Mark
West Pharmaceutical Services, Inc. (NYSE: WST) recently announced it has received 510(k) clearance of the Vial2Bag DC device from the US FDA, and also the…
Ashland to Address Global Drug Development & Bioavailability Enhancement Trends
This past September, Ashland Specialty Ingredients, a commercial unit of Ashland Inc. (NYSE:ASH), opened a state-of-the-art pharmaceutical center of excellence in Wilmington, DE. The new…
Presage Biosciences Granted 5th US Patent for Arrayed Microinjection Platform
Presage Biosciences, an oncology company developing a radical new testing approach that incorporates human efficacy data much earlier in drug development and clinical trials, recently…
Cancer Research Technology Introduces Ximbio
Cancer Research Technology (CRT), the development and commercialization arm of Cancer Research UK, recently announced the launch of Ximbio (www.ximb.io), an online reagents portal for…
Pharmaceutical Industry Feeling Force of Tax Inversion Legislation, says GlobalData Analyst
The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the…
Horizon Discovery Group Launches Collection of Highly Characterized Patient-Derived Xenograft Models of Breast Cancer
Horizon Discovery Group plc (Horizon), a leading provider of products, services and technologies in the field of genome engineering, today announced the launch of its…
